The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Phosphates
potassium phosphates · POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL · Injection, Solution · Intravenous · American Regent, Inc.
NDC 00517-2051-25 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$599.25
Reported to Texas DSHS · 2026 annual filing · American Regent, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- American Regent, Inc.United Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- ANDA216274
- TE code
- AP
- Approval date
- Oct 2, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of potassium phosphates (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Regent, Inc. | POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 4.48 mg/mL; DIBASIC POTASSIUM PHOSPHATE 4.72 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 11.2 mg/mL; DIBASIC POTASSIUM PHOSPHATE 11.8 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| American Regent, Inc. | POTASSIUM PHOSPHATE, MONOBASIC 236 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 224 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 11.8 mg/mL; DIBASIC POTASSIUM PHOSPHATE 11.2 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 4.72 mg/mL; DIBASIC POTASSIUM PHOSPHATE 4.48 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| American Regent, Inc. | POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
| Fresenius Kabi USA, LLC | DIBASIC POTASSIUM PHOSPHATE 4.72 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 4.48 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
| Fresenius Kabi USA, LLC | DIBASIC POTASSIUM PHOSPHATE 11.8 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 11.2 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Phosphates — NDC 00517-2051-25," retrieved September 3, 2026, https://drugdashboards.com/drug/00517205125.
Free to cite with attribution — see how the data is put together.